Investing.com - Financial Markets Worldwide

Scinai Immunotherapeutics Ltd ADR (SCNI)

NASDAQ
Symbol
Exchange
Currency
SCNI·NASDAQ·USD
2F5y·Frankfurt·EUR
Currency in USD
1.470
+0.010(+0.68%)
Closed·
After Hours
1.400-0.070(-4.76%)
·
SCNI Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Trading near 52-week Low
Fair Value
Unlock Value
Day's Range
1.4001.550
52 wk Range
1.4006.180
Key Statistics
Edit
Prev. Close
1.46
Open
1.47
Day's Range
1.4-1.55
52 wk Range
1.4-6.18
Volume
200.63K
Average Volume (3m)
1.32M
1-Year Change
-62.02%
Book Value / Share
5.1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SCNI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 15
RSI suggests the stock is in oversold territory
Unlock InvestingPro

Scinai Immunotherapeutics Ltd ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Scinai Immunotherapeutics Ltd ADR Company Profile

Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson’s syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
31
Market
United States

Compare SCNI to Peers and Sector

Metrics to compare
SCNI
Peers
Sector
Relationship
P/E Ratio
-−2.8x−0.5x
PEG Ratio
-−0.100.00
Price/Book
0.3x3.8x2.6x
Price / LTM Sales
2.1x11.0x3.3x
Upside (Analyst Target)
-418.4%45.1%
Fair Value Upside
Unlock0.5%7.4%Unlock

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-5.69 / --
Revenue / Forecast
206.00K / --
EPS Revisions
a
a
Unlock
Last 90 days

SCNI Income Statement

People Also Watch

Sarepta
15.91
SRPT
-3.11%
Salarius Pharmaceuticals
0.6300
SLRX
+5.12%
Klotho Neuroscience
0.92
KLTO
-4.15%
Bitmine Immersion Tech
31.68
BMNR
-8.55%
INmune Bio
2.56
INMB
-6.23%

FAQ

What Stock Exchange Does Scinai Trade On?

Scinai is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Scinai?

The stock symbol for Scinai is "SCNI."

What Is the Scinai Market Cap?

As of today, Scinai market cap is 1.37M.

What Is Scinai's Earnings Per Share (TTM)?

The Scinai EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is SCNI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Scinai Stock Split?

Scinai has split 2 times.

How Many Employees Does Scinai Have?

Scinai has 31 employees.

What is the current trading status of Scinai (SCNI)?

As of 04 Aug 2025, Scinai (SCNI) is trading at a price of 1.47, with a previous close of 1.46. The stock has fluctuated within a day range of 1.40 to 1.55, while its 52-week range spans from 1.40 to 6.18.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.